No-reflow: incidence and detection in the cath-lab

Area of Science:

• Cardiology
• Interventional Cardiology
• Microcirculation Research

Background:

• ST-elevation myocardial infarction (STEMI) treatment aims to restore blood flow.
• Microcirculatory impairment, termed "myocardial no-reflow," can persist post-recanalization.
• No-reflow is linked to adverse short- and long-term outcomes in STEMI patients.

Purpose of the Study:

• To review and discuss various indexes used to assess myocardial no-reflow.
• To highlight methods for no-reflow detection both during cardiac catheterization and post-procedure.
• To emphasize the clinical significance of no-reflow in STEMI management.

Main Methods:

• Review of established and emerging indexes for no-reflow assessment.
• Categorization of indexes based on assessment timing (in-cath-lab vs. post-cath-lab).
• Inclusion of both traditional and advanced diagnostic techniques.

Main Results:

• No-reflow incidence varies (5-50%) based on patient population and detection methods.
• In-cath-lab assessments include TIMI flow grade, TIMI frame count, myocardial blush grade, and coronary flow.
• Post-cath-lab monitoring utilizes ST-segment resolution and advanced imaging (echocardiography, MRI).

Conclusions:

• Accurate assessment of no-reflow is crucial for predicting STEMI patient prognosis.
• A combination of in-cath-lab and post-procedure monitoring provides comprehensive evaluation.
• Further research into novel no-reflow indexes may improve patient outcomes.